Chinese PE Sinocurrent, Hemei Group to set up $1.45b retail-focused M&A fund


The fund will also establish JVs with global consumer brands operating in China to accelerate their localisation as well as internationalisation of Chinese brands.

Chinese EV startup Byton seeks to raise $500m at a valuation of $4b

Byton is backed by China’s retail giant Suning and healthcare services provider Fullshare Holdings.

TriArtisan Capital in talks to buy Chinese restaurant chain P.F. Chang’s for $700m

P.F. Chang’s has about 220 restaurants in the U.S. and dozens more in Mexico, South Korea, the United Arab Emirates and elsewhere.

Greater China grabs top spots in VC deals as activity hits record highs in 2018

Nine of the top ten deals in the year came from Asia of which seven were in China, according to a Preqin report.

China’s WuXi AppTec co-leads $85m round for Bill Gates-backed Schrödinger

The round was joined by life science and tech investors Deerfield Management, Baron, Qiming Venture Partners and GV (formerly known as Google Ventures).

China’s Morningside leads $40m funding in gene therapy developer Apic Bio

Launched in August 2017, Apic Bio is a spinoff from the University of Massachusetts Medical School.

HK-based Gaw Capital continues to pick Chinese office assets, adds one more to kitty

The purchase closely follows Gaw Capital’s acquisition of Ocean Towers, a Grade A office building in Shanghai.

Shenzhen Capital hits first close at $262m for its $525m debut M&A fund

Investors in the fund include Shenzhen Capital Group, Shenzhen City Guidance Fund, UTrust Fund, Shenzhen Huitong Financial Holdings and others.

Chinese diabetes device platform completes $100m Series C round

The latest series C2 round was led by CICC Capital and CLP Group’s health fund and joined by Samsung Venture Investment, Tasly and Ping An Insurance.

Chinese venture funding in US startups slows to a trickle amid tightened scrutiny

Chinese venture funding in U.S. startups crested to a record $3 billion last year, according to New York economic research firm Rhodium Group.